At present, China is reportedly battling a Covid-like scare. Reports suggest a rise in cases of Human Meta-Pneumo Virus (HMPV) which is a respiratory illness with flu-like symptoms.
Despite of social media videos and posts showing China’s health system overburdened, the country’s health ministry has downplayed the outbreak of HMPV.
Recent investigations suggest that HMPV affects the upper respiratory system but can sometimes cause lower respiratory infections too.
There are even claims that China has declared a state of emergency, however, there’s no official confirmation.
According to some reports, the surge in respiratory infections—caused by influenza A, Mycoplasma pneumoniae, Covid-19, and now HMPV—has raised alarms. In response, China’s disease control authority recently piloted a monitoring system specifically for pneumonia of unknown origin, anticipating a seasonal spike in infections during winter and spring.
Also, Read : A New Hope: CF33 which can kill all types of Cancer
A study published in Virology Journal in April 2024 revealed in the aftermath of the COVID-19 pandemic, there has been a surge in human metapneumovirus (HMPV) transmission, surpassing pre-epidemic levels. We aim to elucidate the clinical and epidemiological characteristics of HMPV infections in the post-COVID-19 pandemic era.
As China prepares for increased respiratory infections in the coming months, experts stress the importance of vigilant monitoring, public health measures, and transparent communication to manage both the spread and public concern surrounding HMPV.
IN INDIA
The National Centre for Disease Control (NCDC) confirmed no Human Metapneumovirus (HMPV) cases in India. Dr Atul Goyal, NCDC director, explained that HMPV resembles common cold viruses, causing flu-like symptoms in children and the elderly. He urged people to follow standard precautions, like avoiding close contact when sick, and assured that regular cold or fever medications are sufficient.